Health Canada approves Moderna flu and flu-COVID vaccines for seniors
Health Canada approved Moderna's mFLUSIVA influenza vaccine and its mCOFLU combined flu-COVID-19 shot for adults aged 50 and older on 5 November, marking the first time a country has authorized both products. According to CBC, the approval positions Canada as the pioneer in granting regulatory clearance for the two vaccines, and the news was reported on 6 November. The approval follows Moderna's submission of data on the safety and efficacy of the mRNA-based flu vaccine and the flu-COVID combination, which regulators reviewed before granting clearance.
Դերակատարներ
Health Canada
Moderna
The Canadian Press
National Advisory Committee on Immunization
Pfizer
Տեղադրություններ
Canada
United States
Europe
